{"id": "article-113372_0", "title": "Oropharyngeal Squamous Cell Carcinoma -- Continuing Education Activity", "content": "Oropharyngeal squamous cell carcinoma, commonly known as throat cancer or tonsil cancer, is a type of head and neck cancer that refers to the cancer of the base and posterior one-third of the tongue, the tonsils, soft palate, and posterior and lateral pharyngeal walls. The incidence of oropharyngeal squamous cell carcinoma is increasing in both old and young populations at an alarming level. This activity illustrates the evaluation and management of oropharyngeal squamous cell carcinoma and highlights the role of the interprofessional team in evaluating and treating patients with this condition.", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Continuing Education Activity. Oropharyngeal squamous cell carcinoma, commonly known as throat cancer or tonsil cancer, is a type of head and neck cancer that refers to the cancer of the base and posterior one-third of the tongue, the tonsils, soft palate, and posterior and lateral pharyngeal walls. The incidence of oropharyngeal squamous cell carcinoma is increasing in both old and young populations at an alarming level. This activity illustrates the evaluation and management of oropharyngeal squamous cell carcinoma and highlights the role of the interprofessional team in evaluating and treating patients with this condition."}
{"id": "article-113372_1", "title": "Oropharyngeal Squamous Cell Carcinoma -- Continuing Education Activity", "content": "Objectives: Identify the risk factors for developing oropharyngeal squamous cell carcinoma. Describe the presentation of a patient with oropharyngeal squamous cell carcinoma. Summarize management considerations for patients with oropharyngeal squamous cell carcinoma. Outline the key differentials for the presentation of this condition and complications following treatments. Access free multiple choice questions on this topic.", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Continuing Education Activity. Objectives: Identify the risk factors for developing oropharyngeal squamous cell carcinoma. Describe the presentation of a patient with oropharyngeal squamous cell carcinoma. Summarize management considerations for patients with oropharyngeal squamous cell carcinoma. Outline the key differentials for the presentation of this condition and complications following treatments. Access free multiple choice questions on this topic."}
{"id": "article-113372_2", "title": "Oropharyngeal Squamous Cell Carcinoma -- Introduction", "content": "Oropharyngeal squamous cell carcinoma (OPSCC), commonly known as throat cancer or tonsil cancer, refers to the cancer of the middle part of the pharynx, known as the oropharynx, which extends vertically from the soft palate to the superior area of the hyoid bone and includes the base and posterior one-third of the tongue, the tonsils, soft palate, and posterior and lateral pharyngeal walls. More than 90% of oropharyngeal cancers are squamous cell cancers, which are the cell lining of the oropharynx [1] . Two types of oropharyngeal cancer can be distinguished: HPV-associated, due to an oral human papillomavirus infection, and non-HPV-associated, mainly due\u00a0to tobacco smoking and alcohol use.", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Introduction. Oropharyngeal squamous cell carcinoma (OPSCC), commonly known as throat cancer or tonsil cancer, refers to the cancer of the middle part of the pharynx, known as the oropharynx, which extends vertically from the soft palate to the superior area of the hyoid bone and includes the base and posterior one-third of the tongue, the tonsils, soft palate, and posterior and lateral pharyngeal walls. More than 90% of oropharyngeal cancers are squamous cell cancers, which are the cell lining of the oropharynx [1] . Two types of oropharyngeal cancer can be distinguished: HPV-associated, due to an oral human papillomavirus infection, and non-HPV-associated, mainly due\u00a0to tobacco smoking and alcohol use."}
{"id": "article-113372_3", "title": "Oropharyngeal Squamous Cell Carcinoma -- Introduction", "content": "In addition to the direct invasion of the tissues, oropharyngeal cancer can spread through blood and lymphatics. The major symptoms of oropharyngeal cancer include sore throat, odynophagia, and dysphagia. Diagnosis is made based on biopsy results of the affected tissue. Treatment involves surgery, radiotherapy, chemotherapy, or a combination of these therapies.", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Introduction. In addition to the direct invasion of the tissues, oropharyngeal cancer can spread through blood and lymphatics. The major symptoms of oropharyngeal cancer include sore throat, odynophagia, and dysphagia. Diagnosis is made based on biopsy results of the affected tissue. Treatment involves surgery, radiotherapy, chemotherapy, or a combination of these therapies."}
{"id": "article-113372_4", "title": "Oropharyngeal Squamous Cell Carcinoma -- Etiology", "content": "The etiology of oropharyngeal carcinoma is broadly categorized into HPV-associated and non-HPV-associated carcinomas.", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Etiology. The etiology of oropharyngeal carcinoma is broadly categorized into HPV-associated and non-HPV-associated carcinomas."}
{"id": "article-113372_5", "title": "Oropharyngeal Squamous Cell Carcinoma -- Etiology", "content": "HPV-associated oropharyngeal squamous cell carcinoma occurs in patients who have been infected with the human papillomavirus. Among the many types of human papillomavirus, HPV16 is the most common type found in oropharyngeal cancers [2] . Oral sex and open-mouthed kissing\u00a0are the most common reasons for oral HPV infection [3] .", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Etiology. HPV-associated oropharyngeal squamous cell carcinoma occurs in patients who have been infected with the human papillomavirus. Among the many types of human papillomavirus, HPV16 is the most common type found in oropharyngeal cancers [2] . Oral sex and open-mouthed kissing\u00a0are the most common reasons for oral HPV infection [3] ."}
{"id": "article-113372_6", "title": "Oropharyngeal Squamous Cell Carcinoma -- Etiology", "content": "On the other hand, smoking tobacco and alcohol consumption have been widely identified as the major risk factors for non-HPV-associated oropharyngeal carcinomas [4] . Other less common risk factors include a diet low in vegetables and fruits, betel quid chewing,\u00a0poor nutrition, marijuana smoking, asbestos exposure, and certain genetic\u00a0mutations such as\u00a0P53 mutation and\u00a0CDKN2A (p16)\u00a0mutations [5] [6] [7] .", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Etiology. On the other hand, smoking tobacco and alcohol consumption have been widely identified as the major risk factors for non-HPV-associated oropharyngeal carcinomas [4] . Other less common risk factors include a diet low in vegetables and fruits, betel quid chewing,\u00a0poor nutrition, marijuana smoking, asbestos exposure, and certain genetic\u00a0mutations such as\u00a0P53 mutation and\u00a0CDKN2A (p16)\u00a0mutations [5] [6] [7] ."}
{"id": "article-113372_7", "title": "Oropharyngeal Squamous Cell Carcinoma -- Epidemiology", "content": "Oropharyngeal cancer is the\u00a0sixth most common cancer worldwide [8] .\u00a0HPV 16 is responsible for almost 90% of HPV-positive oropharyngeal cancers, and the prevalence is higher in males than females [9] [10] . The presence of HPV-associated OPSCC is much higher in the tonsils and base of the tongue. HPV-associated OPSCC tends to occur in a younger population\u00a0that smokes and drinks less; a higher percentage are males and report more oral sex partners [11] .", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Epidemiology. Oropharyngeal cancer is the\u00a0sixth most common cancer worldwide [8] .\u00a0HPV 16 is responsible for almost 90% of HPV-positive oropharyngeal cancers, and the prevalence is higher in males than females [9] [10] . The presence of HPV-associated OPSCC is much higher in the tonsils and base of the tongue. HPV-associated OPSCC tends to occur in a younger population\u00a0that smokes and drinks less; a higher percentage are males and report more oral sex partners [11] ."}
{"id": "article-113372_8", "title": "Oropharyngeal Squamous Cell Carcinoma -- Pathophysiology", "content": "In the case of HPV-associated OPSCC, the oral mucosa is exposed to the HPV infection, which persists and is not cleared. This persistence can lead to a precancerous lesion that may regress or not. If it does not, it will eventually progress to invasive OPSCC. Persistent HPV infections may progress to invasive cancer within ten years. However, the majority of these infections are cleared in one to two years [11] .", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Pathophysiology. In the case of HPV-associated OPSCC, the oral mucosa is exposed to the HPV infection, which persists and is not cleared. This persistence can lead to a precancerous lesion that may regress or not. If it does not, it will eventually progress to invasive OPSCC. Persistent HPV infections may progress to invasive cancer within ten years. However, the majority of these infections are cleared in one to two years [11] ."}
{"id": "article-113372_9", "title": "Oropharyngeal Squamous Cell Carcinoma -- Histopathology", "content": "In patients affected by oropharyngeal squamous cell carcinoma, the accumulation of genetic\u00a0changes results in\u00a0progression from mild and moderate dysplasia to severe dysplasia/carcinoma in situ. However,\u00a0in most HPV-positive oropharyngeal cancers, the tumor\u00a0originates deep\u00a0inside the tonsillar crypt epithelium.\u00a0This is why these cancers are neither visible on inspection nor noticeable by superficial brush biopsy [12] .", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Histopathology. In patients affected by oropharyngeal squamous cell carcinoma, the accumulation of genetic\u00a0changes results in\u00a0progression from mild and moderate dysplasia to severe dysplasia/carcinoma in situ. However,\u00a0in most HPV-positive oropharyngeal cancers, the tumor\u00a0originates deep\u00a0inside the tonsillar crypt epithelium.\u00a0This is why these cancers are neither visible on inspection nor noticeable by superficial brush biopsy [12] ."}
{"id": "article-113372_10", "title": "Oropharyngeal Squamous Cell Carcinoma -- History and Physical", "content": "Patients with oropharyngeal cancer can present with a variety of symptoms depending on the location of the tumor. The most common presentations include persistent sore throat, dysphagia, odynophagia, dysarthria, presence of a lump in the neck, and otalgia. In addition, the patients may also complain of voice changes (hoarseness), unexplained weight loss, and hematemesis.", "contents": "Oropharyngeal Squamous Cell Carcinoma -- History and Physical. Patients with oropharyngeal cancer can present with a variety of symptoms depending on the location of the tumor. The most common presentations include persistent sore throat, dysphagia, odynophagia, dysarthria, presence of a lump in the neck, and otalgia. In addition, the patients may also complain of voice changes (hoarseness), unexplained weight loss, and hematemesis."}
{"id": "article-113372_11", "title": "Oropharyngeal Squamous Cell Carcinoma -- History and Physical", "content": "Physical examination of the oropharynx may reveal either an ulcer or a red or white patch on the base\u00a0or posterior one-third of the tongue,\u00a0posterior and lateral pharyngeal walls, soft palate, or tonsils.", "contents": "Oropharyngeal Squamous Cell Carcinoma -- History and Physical. Physical examination of the oropharynx may reveal either an ulcer or a red or white patch on the base\u00a0or posterior one-third of the tongue,\u00a0posterior and lateral pharyngeal walls, soft palate, or tonsils."}
{"id": "article-113372_12", "title": "Oropharyngeal Squamous Cell Carcinoma -- Evaluation", "content": "A comprehensive protocol of investigations should be employed if there is a clinical suspicion of oropharyngeal cancer. These include:", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Evaluation. A comprehensive protocol of investigations should be employed if there is a clinical suspicion of oropharyngeal cancer. These include:"}
{"id": "article-113372_13", "title": "Oropharyngeal Squamous Cell Carcinoma -- Evaluation -- Radiography", "content": "Plain radiography is done for dental assessment and bony invasion, but it is of limited value.", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Evaluation -- Radiography. Plain radiography is done for dental assessment and bony invasion, but it is of limited value."}
{"id": "article-113372_14", "title": "Oropharyngeal Squamous Cell Carcinoma -- Evaluation -- Ultrasonography", "content": "It is recommended to perform ultrasound with or without needle biopsy in all the patients reporting a neck lump because of its excellent accuracy of staging the nodal disease if employed by an experienced operator [13] .", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Evaluation -- Ultrasonography. It is recommended to perform ultrasound with or without needle biopsy in all the patients reporting a neck lump because of its excellent accuracy of staging the nodal disease if employed by an experienced operator [13] ."}
{"id": "article-113372_15", "title": "Oropharyngeal Squamous Cell Carcinoma -- Evaluation -- Magnetic Resonance Imaging (MRI)", "content": "MRI provides excellent visualization of the tumor infiltrating the soft tissue, is not distorted by the metallic dental restorations, and is considered optimal for the staging of the primary tumor [13] .", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Evaluation -- Magnetic Resonance Imaging (MRI). MRI provides excellent visualization of the tumor infiltrating the soft tissue, is not distorted by the metallic dental restorations, and is considered optimal for the staging of the primary tumor [13] ."}
{"id": "article-113372_16", "title": "Oropharyngeal Squamous Cell Carcinoma -- Evaluation -- Computed Tomography (CT)", "content": "A CT scan can not only be utilized to\u00a0estimate the size of the tumor\u00a0but also assist in\u00a0deciding on surgical removal of the tumor and\u00a0its spread to the lymph nodes in the neck or lower mandible.", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Evaluation -- Computed Tomography (CT). A CT scan can not only be utilized to\u00a0estimate the size of the tumor\u00a0but also assist in\u00a0deciding on surgical removal of the tumor and\u00a0its spread to the lymph nodes in the neck or lower mandible."}
{"id": "article-113372_17", "title": "Oropharyngeal Squamous Cell Carcinoma -- Evaluation -- Positron Emission Tomography (PET)", "content": "PET combined with CT-scan should be employed\u00a0in cases where conventional cross-sectional imaging fails to identify primary tumors [13] .\u00a0PET scan is also employed\u00a0for the assessment and detection of the recurrence of the primary tumors [13] .", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Evaluation -- Positron Emission Tomography (PET). PET combined with CT-scan should be employed\u00a0in cases where conventional cross-sectional imaging fails to identify primary tumors [13] .\u00a0PET scan is also employed\u00a0for the assessment and detection of the recurrence of the primary tumors [13] ."}
{"id": "article-113372_18", "title": "Oropharyngeal Squamous Cell Carcinoma -- Evaluation -- Endoscopy and Laryngoscopy", "content": "Endoscopy and laryngoscopy\u00a0are performed after using an anesthetic spray or general anesthesia to visualize and examine the suspicious sites in detail and take the biopsy sample.", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Evaluation -- Endoscopy and Laryngoscopy. Endoscopy and laryngoscopy\u00a0are performed after using an anesthetic spray or general anesthesia to visualize and examine the suspicious sites in detail and take the biopsy sample."}
{"id": "article-113372_19", "title": "Oropharyngeal Squamous Cell Carcinoma -- Evaluation -- Biopsy", "content": "A biopsy of the suspicious area is performed to make a definitive diagnosis. The type of biopsy i.e., a fine-needle aspiration biopsy using a fine needle to collect a sample or oral brush biopsy, which is a newer, simpler, and more convenient method employing a small brush to collect the sample during routine dental examinations, depends upon the location of the cancer.", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Evaluation -- Biopsy. A biopsy of the suspicious area is performed to make a definitive diagnosis. The type of biopsy i.e., a fine-needle aspiration biopsy using a fine needle to collect a sample or oral brush biopsy, which is a newer, simpler, and more convenient method employing a small brush to collect the sample during routine dental examinations, depends upon the location of the cancer."}
{"id": "article-113372_20", "title": "Oropharyngeal Squamous Cell Carcinoma -- Evaluation -- Human Papillomavirus Testing (HPV testing)", "content": "The American Society of Clinical Oncology recommends that HPV testing should be done on all newly diagnosed oropharyngeal cancers. This is done by polymerase chain reaction, which detects the HPV DNA.", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Evaluation -- Human Papillomavirus Testing (HPV testing). The American Society of Clinical Oncology recommends that HPV testing should be done on all newly diagnosed oropharyngeal cancers. This is done by polymerase chain reaction, which detects the HPV DNA."}
{"id": "article-113372_21", "title": "Oropharyngeal Squamous Cell Carcinoma -- Treatment / Management", "content": "Surgery and radiotherapy are the two principle modalities used in the treatment of patients suffering from oropharyngeal cancers. Surgery or radiotherapy can be used primarily if\u00a0the tumor is small and has not advanced. However, if the disease has advanced or the tumor is larger, then a combination of surgery and radiotherapy is used. Implementing minimally invasive procedures, such as transoral laser microsurgery (TLM), as a first-line treatment modality for\u00a0oropharyngeal carcinomas have been found safe and efficacious [14] . Other resection methods include\u00a0transoral robotic surgery, transoral video laryngoscopic surgery, transoral ultrasound surgery, and endoscopic laryngopharyngeal surgery [15] .", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Treatment / Management. Surgery and radiotherapy are the two principle modalities used in the treatment of patients suffering from oropharyngeal cancers. Surgery or radiotherapy can be used primarily if\u00a0the tumor is small and has not advanced. However, if the disease has advanced or the tumor is larger, then a combination of surgery and radiotherapy is used. Implementing minimally invasive procedures, such as transoral laser microsurgery (TLM), as a first-line treatment modality for\u00a0oropharyngeal carcinomas have been found safe and efficacious [14] . Other resection methods include\u00a0transoral robotic surgery, transoral video laryngoscopic surgery, transoral ultrasound surgery, and endoscopic laryngopharyngeal surgery [15] ."}
{"id": "article-113372_22", "title": "Oropharyngeal Squamous Cell Carcinoma -- Treatment / Management", "content": "Following surgery, survival is increased in patients undergoing induction chemotherapy or concomitant chemoradiotherapy. In the case of unresectable tumors,\u00a0concomitant cisplatin-based chemotherapy, along with radiotherapy, is considered the gold standard and has shown to be better in terms of improving survival as compared to radiotherapy alone [16] .\u00a0However, some studies have shown a parallel prognostic profile of concomitant use of carboplatin/paclitaxel in stage\u00a0III and IV non-metastatic oropharyngeal carcinomas but with fewer adverse effects [17] .", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Treatment / Management. Following surgery, survival is increased in patients undergoing induction chemotherapy or concomitant chemoradiotherapy. In the case of unresectable tumors,\u00a0concomitant cisplatin-based chemotherapy, along with radiotherapy, is considered the gold standard and has shown to be better in terms of improving survival as compared to radiotherapy alone [16] .\u00a0However, some studies have shown a parallel prognostic profile of concomitant use of carboplatin/paclitaxel in stage\u00a0III and IV non-metastatic oropharyngeal carcinomas but with fewer adverse effects [17] ."}
{"id": "article-113372_23", "title": "Oropharyngeal Squamous Cell Carcinoma -- Differential Diagnosis", "content": "The conditions with presentations similar to oropharyngeal squamous cell carcinoma and which need to be excluded include: Actinic keratosis Erythroplasia Lichen planus Leukoplakias Lichenoid lesions Oral candidiasis Tonsillitis Traumatic lesions", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Differential Diagnosis. The conditions with presentations similar to oropharyngeal squamous cell carcinoma and which need to be excluded include: Actinic keratosis Erythroplasia Lichen planus Leukoplakias Lichenoid lesions Oral candidiasis Tonsillitis Traumatic lesions"}
{"id": "article-113372_24", "title": "Oropharyngeal Squamous Cell Carcinoma -- Staging", "content": "The American Joint Committee\u00a0on Cancer (AJCC) has defined the staging of oropharyngeal cancer. This follows a TNM staging system where T\u00a0relates to\u00a0the extent of the primary tumor, N indicates the involvement of regional lymph nodes, and M specifies the distant metastasis. In their 8th edition of the staging manual, AJCC has modified the staging system being used for staging oropharyngeal cancer with the addition of depth of invasion (DOI) of the primary tumor as a modification to the T category and extranodal extension (ENE) to upstage node-positive\u00a0oropharyngeal squamous cell carcinoma [18] . The new version of classification is more complex than its previous one, but it is better in terms of\u00a0stratifying survival of oropharyngeal squamous cell carcinoma\u00a0patients by stage [19] .", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Staging. The American Joint Committee\u00a0on Cancer (AJCC) has defined the staging of oropharyngeal cancer. This follows a TNM staging system where T\u00a0relates to\u00a0the extent of the primary tumor, N indicates the involvement of regional lymph nodes, and M specifies the distant metastasis. In their 8th edition of the staging manual, AJCC has modified the staging system being used for staging oropharyngeal cancer with the addition of depth of invasion (DOI) of the primary tumor as a modification to the T category and extranodal extension (ENE) to upstage node-positive\u00a0oropharyngeal squamous cell carcinoma [18] . The new version of classification is more complex than its previous one, but it is better in terms of\u00a0stratifying survival of oropharyngeal squamous cell carcinoma\u00a0patients by stage [19] ."}
{"id": "article-113372_25", "title": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Primary Tumor (T)", "content": "T0-Primary tumor cannot be assessed T1-Tumor\u00a0smaller than 2cm in greatest dimension T2-Tumor larger\u00a0than 2cm but smaller than 4cm\u00a0in greatest dimension T3-Tumor larger\u00a0than 4cm or extension to the lingual surface of epiglottis T4-Moderately advanced local disease; tumor invades the larynx, extrinsic muscle of tongue, medial pterygoid, hard palate, or mandible or beyond T4a-Moderately advanced local disease; tumor invades the larynx, extrinsic muscle of tongue, medial pterygoid, hard palate, or mandible T4b-Very advanced local disease; tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base or encases carotid artery", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Primary Tumor (T). T0-Primary tumor cannot be assessed T1-Tumor\u00a0smaller than 2cm in greatest dimension T2-Tumor larger\u00a0than 2cm but smaller than 4cm\u00a0in greatest dimension T3-Tumor larger\u00a0than 4cm or extension to the lingual surface of epiglottis T4-Moderately advanced local disease; tumor invades the larynx, extrinsic muscle of tongue, medial pterygoid, hard palate, or mandible or beyond T4a-Moderately advanced local disease; tumor invades the larynx, extrinsic muscle of tongue, medial pterygoid, hard palate, or mandible T4b-Very advanced local disease; tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base or encases carotid artery"}
{"id": "article-113372_26", "title": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Regional Lymph Nodes (N)", "content": "NX-Regional lymph nodes cannot be assessed pN0-No regional lymph node metastasis pN1-Metastasis in 4 or fewer lymph nodes pN2-Metastasis in more than four lymph nodes", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Regional Lymph Nodes (N). NX-Regional lymph nodes cannot be assessed pN0-No regional lymph node metastasis pN1-Metastasis in 4 or fewer lymph nodes pN2-Metastasis in more than four lymph nodes"}
{"id": "article-113372_27", "title": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Metastasis (M)", "content": "M0-No distant metastasis M1-Distant metastasis", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Metastasis (M). M0-No distant metastasis M1-Distant metastasis"}
{"id": "article-113372_28", "title": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Stage I", "content": "T0\u2013T2N0M0 T0\u2013T2N1M0", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Stage I. T0\u2013T2N0M0 T0\u2013T2N1M0"}
{"id": "article-113372_29", "title": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Stage II", "content": "T0\u2013T2N2M0 T3N0\u2013N2M0", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Stage II. T0\u2013T2N2M0 T3N0\u2013N2M0"}
{"id": "article-113372_30", "title": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Stage III", "content": "T0\u2013T3N3M0 T4N0\u2013N3M0", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Stage III. T0\u2013T3N3M0 T4N0\u2013N3M0"}
{"id": "article-113372_31", "title": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Stage IV", "content": "Any T/Any N M1", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Stage IV. Any T/Any N M1"}
{"id": "article-113372_32", "title": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Stage I", "content": "T0\u2013T2N0M0 T0\u2013T2N1M0", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Stage I. T0\u2013T2N0M0 T0\u2013T2N1M0"}
{"id": "article-113372_33", "title": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Stage II", "content": "T0\u2013T2N2M0 T3\u2013T4N0M0 T3\u2013T4N1M0", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Stage II. T0\u2013T2N2M0 T3\u2013T4N0M0 T3\u2013T4N1M0"}
{"id": "article-113372_34", "title": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Stage III", "content": "T3\u2013T4N2M0", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Stage III. T3\u2013T4N2M0"}
{"id": "article-113372_35", "title": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Stage IV", "content": "Any T/Any N M1", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Stage IV. Any T/Any N M1"}
{"id": "article-113372_36", "title": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Primary tumor (T)", "content": "Tx-Primary tumor cannot be assessed Tis-Carcinoma in situ T1-Tumor 2 cm or smaller in greatest dimension T2-Tumor larger than 2 cm but not larger than 4 cm in greatest dimension T3-Tumor larger than 4 cm in greatest dimension or extension to the lingual surface of epiglottis T4-Moderately advanced or very advanced local disease T4a-Moderately advanced local disease; tumor invades the larynx, extrinsic muscle of tongue, medial pterygoid, hard palate, or mandible T4b-Very advanced local disease; tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base or encases carotid artery", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Primary tumor (T). Tx-Primary tumor cannot be assessed Tis-Carcinoma in situ T1-Tumor 2 cm or smaller in greatest dimension T2-Tumor larger than 2 cm but not larger than 4 cm in greatest dimension T3-Tumor larger than 4 cm in greatest dimension or extension to the lingual surface of epiglottis T4-Moderately advanced or very advanced local disease T4a-Moderately advanced local disease; tumor invades the larynx, extrinsic muscle of tongue, medial pterygoid, hard palate, or mandible T4b-Very advanced local disease; tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base or encases carotid artery"}
{"id": "article-113372_37", "title": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Regional lymph nodes (N)", "content": "N0-No regional lymph node metastasis", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Regional lymph nodes (N). N0-No regional lymph node metastasis"}
{"id": "article-113372_38", "title": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Regional lymph nodes (N)", "content": "N1-Metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE-negative", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Regional lymph nodes (N). N1-Metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE-negative"}
{"id": "article-113372_39", "title": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Regional lymph nodes (N)", "content": "N2-Metastasis in a single ipsilateral lymph node larger than 3 cm but not larger than 6 cm in greatest dimension and ENE-negative; or metastases in multiple ipsilateral lymph nodes, none larger than 6 cm in greatest dimension and ENE-negative; or metastasis in bilateral or contralateral lymph nodes, none larger than 6 cm in greatest dimension and ENE-negative", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Regional lymph nodes (N). N2-Metastasis in a single ipsilateral lymph node larger than 3 cm but not larger than 6 cm in greatest dimension and ENE-negative; or metastases in multiple ipsilateral lymph nodes, none larger than 6 cm in greatest dimension and ENE-negative; or metastasis in bilateral or contralateral lymph nodes, none larger than 6 cm in greatest dimension and ENE-negative"}
{"id": "article-113372_40", "title": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Regional lymph nodes (N)", "content": "N2a-Metastasis in a single ipsilateral lymph node larger than 3 cm but not larger than 6 cm in greatest dimension and ENE-negative", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Regional lymph nodes (N). N2a-Metastasis in a single ipsilateral lymph node larger than 3 cm but not larger than 6 cm in greatest dimension and ENE-negative"}
{"id": "article-113372_41", "title": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Regional lymph nodes (N)", "content": "N2b-Metastasis in multiple ipsilateral lymph nodes, none larger than 6 cm in greatest dimension and ENE-negative", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Regional lymph nodes (N). N2b-Metastasis in multiple ipsilateral lymph nodes, none larger than 6 cm in greatest dimension and ENE-negative"}
{"id": "article-113372_42", "title": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Regional lymph nodes (N)", "content": "N2c-Metastasis in bilateral or contralateral lymph nodes, none larger than 6 cm in greatest dimension and ENE-negative", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Regional lymph nodes (N). N2c-Metastasis in bilateral or contralateral lymph nodes, none larger than 6 cm in greatest dimension and ENE-negative"}
{"id": "article-113372_43", "title": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Regional lymph nodes (N)", "content": "N3-Metastasis in a lymph node larger than 6 cm in greatest dimension and ENE-negative; or metastasis in any lymph node(s) and clinically overt ENE-positive", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Regional lymph nodes (N). N3-Metastasis in a lymph node larger than 6 cm in greatest dimension and ENE-negative; or metastasis in any lymph node(s) and clinically overt ENE-positive"}
{"id": "article-113372_44", "title": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Regional lymph nodes (N)", "content": "N3a-Metastasis in a lymph node larger than 6 cm in greatest dimension and ENE-negative", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Regional lymph nodes (N). N3a-Metastasis in a lymph node larger than 6 cm in greatest dimension and ENE-negative"}
{"id": "article-113372_45", "title": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Regional lymph nodes (N)", "content": "N3b-Metastasis in any node(s) and clinically overt ENE-positive", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Regional lymph nodes (N). N3b-Metastasis in any node(s) and clinically overt ENE-positive"}
{"id": "article-113372_46", "title": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Metastasis", "content": "M0-No distant metastasis M1-Distant metastasis", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Metastasis. M0-No distant metastasis M1-Distant metastasis"}
{"id": "article-113372_47", "title": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Stage\u00a00", "content": "TisN0M0", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Stage\u00a00. TisN0M0"}
{"id": "article-113372_48", "title": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Stage I", "content": "T1N0M0", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Stage I. T1N0M0"}
{"id": "article-113372_49", "title": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Stage II", "content": "T2N0M0", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Stage II. T2N0M0"}
{"id": "article-113372_50", "title": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Stage III", "content": "T3N0M0 T1N1M0 T2N1M0 T3N1M0", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Stage III. T3N0M0 T1N1M0 T2N1M0 T3N1M0"}
{"id": "article-113372_51", "title": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Stage IVA", "content": "T4aN0M0 T4aN1M0 T1N2M0 T2N2M0 T3N2M0 T4aN2M0", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Stage IVA. T4aN0M0 T4aN1M0 T1N2M0 T2N2M0 T3N2M0 T4aN2M0"}
{"id": "article-113372_52", "title": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Stage IVB", "content": "AnyTN3M0 T4bAnyNM0", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Stage IVB. AnyTN3M0 T4bAnyNM0"}
{"id": "article-113372_53", "title": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Stage IVC", "content": "AnyTAnyNM1", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Staging -- Stage IVC. AnyTAnyNM1"}
{"id": "article-113372_54", "title": "Oropharyngeal Squamous Cell Carcinoma -- Prognosis", "content": "The overall five-year survival rate in oropharyngeal carcinoma is around 60%. However, the prognosis varies\u00a0depending on the etiology. In comparison to HPV-negative oropharyngeal squamous cell carcinoma, HPV-positive oropharyngeal carcinoma shows a better prognosis and increased response to the treatment. [20] The higher survival with HPV-associated cancer is\u00a0because of favorable tumor biology and a healthier and\u00a0younger patient population.", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Prognosis. The overall five-year survival rate in oropharyngeal carcinoma is around 60%. However, the prognosis varies\u00a0depending on the etiology. In comparison to HPV-negative oropharyngeal squamous cell carcinoma, HPV-positive oropharyngeal carcinoma shows a better prognosis and increased response to the treatment. [20] The higher survival with HPV-associated cancer is\u00a0because of favorable tumor biology and a healthier and\u00a0younger patient population."}
{"id": "article-113372_55", "title": "Oropharyngeal Squamous Cell Carcinoma -- Complications", "content": "Treatment modalities employed in oropharyngeal cancers can result in several complications, such as: Oral mucositis Tissue fibrosis Hyposalivation Infection Osteoradionecrosis Morbidity from jaw resection, disfigurement, and loss of function can\u00a0further\u00a0reduce\u00a0quality of life. [21]", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Complications. Treatment modalities employed in oropharyngeal cancers can result in several complications, such as: Oral mucositis Tissue fibrosis Hyposalivation Infection Osteoradionecrosis Morbidity from jaw resection, disfigurement, and loss of function can\u00a0further\u00a0reduce\u00a0quality of life. [21]"}
{"id": "article-113372_56", "title": "Oropharyngeal Squamous Cell Carcinoma -- Deterrence and Patient Education", "content": "Regarding primary prevention of HPV-related OPSCC, HPV vaccines are more than 90% effective in preventing vaccine-type HPV infections and their\u00a0correlated\u00a0anogenital precancerous lesions. Pinto et al. demonstrated that vaccination induces HPV antibody levels in the oral cavity that correlate with circulating levels [11] . A screening tool useful in the early detection of HPV-DNA in oral rinses is promising, but very little data is available [11] .", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Deterrence and Patient Education. Regarding primary prevention of HPV-related OPSCC, HPV vaccines are more than 90% effective in preventing vaccine-type HPV infections and their\u00a0correlated\u00a0anogenital precancerous lesions. Pinto et al. demonstrated that vaccination induces HPV antibody levels in the oral cavity that correlate with circulating levels [11] . A screening tool useful in the early detection of HPV-DNA in oral rinses is promising, but very little data is available [11] ."}
{"id": "article-113372_57", "title": "Oropharyngeal Squamous Cell Carcinoma -- Deterrence and Patient Education", "content": "Safe oral sex habits should be advised.\u00a0Educating the patients on the risks of betel quid chewing, alcohol use, and tobacco\u00a0smoking is of prime importance in controlling and preventing oropharyngeal cancers.", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Deterrence and Patient Education. Safe oral sex habits should be advised.\u00a0Educating the patients on the risks of betel quid chewing, alcohol use, and tobacco\u00a0smoking is of prime importance in controlling and preventing oropharyngeal cancers."}
{"id": "article-113372_58", "title": "Oropharyngeal Squamous Cell Carcinoma -- Pearls and Other Issues", "content": "New and remarkable achievements have been developed regarding the strategies employed in oropharyngeal cancer diagnosis and treatment. These include the use of LASER-based technology to detect oropharyngeal squamous cell carcinoma at the early stages, especially in limited-resource settings, and\u00a0targeted therapy, which detects the mutations in genes that result in cancer and correct them, either inhibiting the growth of the tumor, its metastasis or target vascularity, cell signaling or transduction pathways [22] . In addition, the Food and Drug Administration (FDA) has approved vaccination against HPV to prevent HPV-related infections, reducing the incidence of oropharyngeal cancers.", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Pearls and Other Issues. New and remarkable achievements have been developed regarding the strategies employed in oropharyngeal cancer diagnosis and treatment. These include the use of LASER-based technology to detect oropharyngeal squamous cell carcinoma at the early stages, especially in limited-resource settings, and\u00a0targeted therapy, which detects the mutations in genes that result in cancer and correct them, either inhibiting the growth of the tumor, its metastasis or target vascularity, cell signaling or transduction pathways [22] . In addition, the Food and Drug Administration (FDA) has approved vaccination against HPV to prevent HPV-related infections, reducing the incidence of oropharyngeal cancers."}
{"id": "article-113372_59", "title": "Oropharyngeal Squamous Cell Carcinoma -- Enhancing Healthcare Team Outcomes", "content": "An interprofessional team consisting of an oncologist, psychotherapist, dentist, dietitian, histopathologist, surgeon, radiation oncologist, otorhinolaryngologist, clinical speech pathologist, a dental hygienist, and a chemotherapy nurse should work in collaboration to arrive at the best possible outcomes regarding the diagnosis and management of such patients [23] .", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Enhancing Healthcare Team Outcomes. An interprofessional team consisting of an oncologist, psychotherapist, dentist, dietitian, histopathologist, surgeon, radiation oncologist, otorhinolaryngologist, clinical speech pathologist, a dental hygienist, and a chemotherapy nurse should work in collaboration to arrive at the best possible outcomes regarding the diagnosis and management of such patients [23] ."}
{"id": "article-113372_60", "title": "Oropharyngeal Squamous Cell Carcinoma -- Enhancing Healthcare Team Outcomes", "content": "These professionals are also in an\u00a0optimal position to influence and advise patients on quitting smoking\u00a0and limiting alcohol in addition to maintaining healthy lifestyle habits such as eating fruits and vegetables,\u00a0observing dental hygiene, and having safe sex, which may contribute to preventing the increasing incidence of oropharyngeal squamous cell carcinoma.", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Enhancing Healthcare Team Outcomes. These professionals are also in an\u00a0optimal position to influence and advise patients on quitting smoking\u00a0and limiting alcohol in addition to maintaining healthy lifestyle habits such as eating fruits and vegetables,\u00a0observing dental hygiene, and having safe sex, which may contribute to preventing the increasing incidence of oropharyngeal squamous cell carcinoma."}
{"id": "article-113372_61", "title": "Oropharyngeal Squamous Cell Carcinoma -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Oropharyngeal Squamous Cell Carcinoma -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}